Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2021-07-03
DOI
10.1080/13543784.2021.1951702
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improvement of cognitive function, glucose and lipid homeostasis and serum osteocalcin levels by liraglutide in diabetic rats
- (2021) Amina Ahmed Sedky FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study
- (2020) Francesco Vadini et al. INTERNATIONAL JOURNAL OF OBESITY
- A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca2+ homeostasis in 3xTg-AD mice
- (2020) Tian Li et al. NEUROPHARMACOLOGY
- The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder
- (2020) Adriano José Maia Chaves Filho et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- GLP-1 mimetics and cognition
- (2020) Habib Yaribeygi et al. LIFE SCIENCES
- Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation
- (2020) Haoqiang Zhang et al. Aging-US
- Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex
- (2019) Éva A. Csajbók et al. DIABETOLOGIA
- Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
- (2019) Robert A. McCutcheon et al. TRENDS IN NEUROSCIENCES
- Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia
- (2019) S. Andrea Wijtenburg et al. SCHIZOPHRENIA RESEARCH
- Dietary intake of people with severe mental illness: systematic review and meta-analysis
- (2019) Scott B. Teasdale et al. BRITISH JOURNAL OF PSYCHIATRY
- Brain insulin action: implications for the treatment of schizophrenia
- (2019) Sri Mahavir Agarwal et al. NEUROPHARMACOLOGY
- Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5×FAD mouse model of Alzheimer’s disease
- (2019) Jingjing An et al. BEHAVIOURAL BRAIN RESEARCH
- The origin of NMDA receptor hypofunction in schizophrenia
- (2019) Kazu Nakazawa et al. PHARMACOLOGY & THERAPEUTICS
- An evaluation of liraglutide including its efficacy and safety for the treatment of obesity
- (2019) Chen-Hsiu Lin et al. EXPERT OPINION ON PHARMACOTHERAPY
- Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease
- (2019) Geisa Nogueira Salles et al. NEUROPHARMACOLOGY
- Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure
- (2019) Gwangho Yoon et al. PHARMACOLOGICAL RESEARCH
- Immune and metabolic alterations in first episode psychosis (FEP) patients
- (2018) Luisella Bocchio-Chiavetto et al. BRAIN BEHAVIOR AND IMMUNITY
- Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease
- (2018) Jingjing Tai et al. BRAIN RESEARCH
- DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease
- (2018) Yue Cao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease
- (2018) Tian Li et al. HIPPOCAMPUS
- Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats
- (2018) Ilijana Babic et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats
- (2018) Ying Yang et al. Molecular Medicine Reports
- Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes
- (2018) Fei-Juan Kong et al. NEUROPHARMACOLOGY
- GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling
- (2018) Ying Wang et al. NEUROPHARMACOLOGY
- Insulin Regulates GABAA Receptor-Mediated Tonic Currents in the Prefrontal Cortex
- (2018) Saraí Trujeque-Ramos et al. Frontiers in Neuroscience
- Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation Strategies
- (2018) Adarsh Tripathi et al. Clinical Psychopharmacology and Neuroscience
- Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
- (2018) Wen-Yu Hsu et al. Frontiers in Psychiatry
- Glutamatergic Alterations in STZ-Induced Diabetic Rats Are Reversed by Exendin-4
- (2018) Caroline Zanotto et al. MOLECULAR NEUROBIOLOGY
- OUP accepted manuscript
- (2018) SCHIZOPHRENIA BULLETIN
- Glucose metabolism dysregulation at the onset of mental illness is not limited to first episode psychosis: A systematic review and meta-analysis
- (2018) Suat Kucukgoncu et al. Early Intervention in Psychiatry
- Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
- (2018) Nicole E. MacKenzie et al. Frontiers in Psychiatry
- Evidence of metabolic memory-induced neurodegeneration and the therapeutic effects of glucagon-like peptide-1 receptor agonists via Forkhead box class O
- (2018) Song Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease
- (2017) Ziyue Yuan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study
- (2017) Rodrigo B. Mansur et al. JOURNAL OF AFFECTIVE DISORDERS
- Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice
- (2017) Shuyi Chen et al. NEUROCHEMICAL RESEARCH
- Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis
- (2017) Anne Marie Greenhalgh et al. SCHIZOPHRENIA RESEARCH
- Impaired Glucose Homeostasis in First-Episode Schizophrenia
- (2017) Toby Pillinger et al. JAMA Psychiatry
- Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia
- (2017) Zachary Freyberg et al. Frontiers in Neuroscience
- Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats
- (2016) Enas S. Gad et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial
- (2016) Olivia M. Farr et al. DIABETOLOGIA
- Neurobehavioral effects of liraglutide and sitagliptin in experimental models
- (2016) Mayur Kamble et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Exenatide enhances cognitive performance and upregulates neurotrophic factor gene expression levels in diabetic mice
- (2016) Esen Gumuslu et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis
- (2016) E. Bora et al. PSYCHOLOGICAL MEDICINE
- RDoC: Translating promise into progress
- (2016) Christopher J. Patrick et al. PSYCHOPHYSIOLOGY
- A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia
- (2016) Stefanie Malan-Müller et al. SCHIZOPHRENIA RESEARCH
- How sedentary are people with psychosis? A systematic review and meta-analysis
- (2016) Brendon Stubbs et al. SCHIZOPHRENIA RESEARCH
- Modeling combined schizophrenia-related behavioral and metabolic phenotypes in rodents
- (2015) Zoltán Sarnyai et al. BEHAVIOURAL BRAIN RESEARCH
- The effect of isoliquiritigenin on learning and memory impairments induced by high-fat diet via inhibiting TNF-α/JNK/IRS signaling
- (2015) Xiao Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Meta-Analysis of Cognitive Functioning in Nondemented Adults with Type 2 Diabetes Mellitus
- (2014) Michelle C.E. Monette et al. Canadian Journal of Diabetes
- GLP-1 and Exendin-4 Transiently Enhance GABAAReceptor–Mediated Synaptic and Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons
- (2014) Sergiy V. Korol et al. DIABETES
- GABAergic Neurogliaform Cells Represent Local Sources of Insulin in the Cerebral Cortex
- (2014) G. Molnar et al. JOURNAL OF NEUROSCIENCE
- Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats
- (2014) H.-Y. Cai et al. NEUROSCIENCE
- Lixisenatide improves recognition memory and exerts neuroprotective actions in high-fat fed mice
- (2014) Rachael Lennox et al. PEPTIDES
- Psychological predictors of functional outcome in people with schizophrenia
- (2014) Jacqueline N. Kiwanuka et al. SCHIZOPHRENIA RESEARCH
- Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
- (2014) Rachel Upthegrove et al. SCHIZOPHRENIA RESEARCH
- Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia
- (2014) N J M van Beveren et al. Translational Psychiatry
- Insulin in the Brain: Its Pathophysiological Implications for States Related with Central Insulin Resistance, Type 2 Diabetes and Alzheimer’s Disease
- (2014) Enrique Blázquez et al. Frontiers in Endocrinology
- Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders
- (2013) Rasoul Ghasemi et al. MOLECULAR NEUROBIOLOGY
- Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
- (2013) Paula L. McClean et al. NEUROPHARMACOLOGY
- Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6
- (2013) R. Shirazi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response
- (2013) Milica Borovcanin et al. SCHIZOPHRENIA RESEARCH
- GLP-1R agonist therapy for diabetes
- (2013) Susan L. Samson et al. Current Opinion in Endocrinology Diabetes and Obesity
- The neuroprotective effects of GLP-1: Possible treatments for cognitive deficits in individuals with mood disorders
- (2012) Roger S. McIntyre et al. BEHAVIOURAL BRAIN RESEARCH
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
- (2012) Theresa R. Bomfim et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
- (2012) C S Weickert et al. MOLECULAR PSYCHIATRY
- The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease
- (2012) Caitriona M. Long-Smith et al. NEUROMOLECULAR MEDICINE
- Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice
- (2012) David Porter et al. PEPTIDES
- Exendin-4 Protected against Cognitive Dysfunction in Hyperglycemic Mice Receiving an Intrahippocampal Lipopolysaccharide Injection
- (2012) Hei-Jen Huang et al. PLoS One
- Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia
- (2012) Xiang Yang Zhang et al. PSYCHOPHARMACOLOGY
- Diabetes is associated with lower global cognitive function in schizophrenia
- (2012) Yoichiro Takayanagi et al. SCHIZOPHRENIA RESEARCH
- Relationship between metabolic syndrome and cognition in patients with schizophrenia
- (2012) Jean Pierre Lindenmayer et al. SCHIZOPHRENIA RESEARCH
- NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis
- (2011) Gary Gilmour et al. NEUROPHARMACOLOGY
- New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats
- (2011) T.J. Bussey et al. NEUROPHARMACOLOGY
- Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond
- (2011) Urs Meyer et al. PHARMACOLOGY & THERAPEUTICS
- Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats
- (2011) Agnieszka Nikiforuk et al. PSYCHOPHARMACOLOGY
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
- (2011) Alex J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Insulin and the brain
- (2011) Zvi Laron ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
- (2011) Eléonore Beurel Frontiers in Molecular Neuroscience
- The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test
- (2010) Ruben Isacson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Expression of the Hippocampal NMDA Receptor GluN1 Subunit and Its Splicing Isoforms in Schizophrenia: Postmortem Study
- (2010) Monika Vrajová et al. NEUROCHEMICAL RESEARCH
- The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study
- (2010) Robert S. Kern et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
- (2009) Mario Álvarez-Jiménez et al. CNS DRUGS
- A comprehensive definition for metabolic syndrome
- (2009) P. L. Huang Disease Models & Mechanisms
- Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease
- (2009) Paula L. McClean et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of second-generation antipsychotics on cognition: current issues and future challenges
- (2009) S Kristian Hill et al. Expert Review of Neurotherapeutics
- Impairment of episodic and semantic autobiographical memory in patients with mild cognitive impairment and early Alzheimer's disease
- (2009) Thomas Leyhe et al. NEUROPSYCHOLOGIA
- The influences of juvenile diabetes on memory and hippocampal plasticity in rats: Improving effects of glucagon-like peptide-1
- (2009) Takashi Iwai et al. NEUROSCIENCE RESEARCH
- The role of GSK-3 in synaptic plasticity
- (2008) S Peineau et al. BRITISH JOURNAL OF PHARMACOLOGY
- Glucose and GLP-1 Stimulate cAMP Production via Distinct Adenylyl Cyclases in INS-1E Insulinoma Cells
- (2008) Lavoisier S. Ramos et al. JOURNAL OF GENERAL PHYSIOLOGY
- New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer’s disease?
- (2008) Christian Hölscher et al. NEUROBIOLOGY OF AGING
- Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia
- (2008) Scot E. Purdon et al. SCHIZOPHRENIA RESEARCH
- Progressive Brain Volume Loss in Schizophrenia Over the Course of the Illness: Evidence of Maturational Abnormalities in Early Adulthood
- (2007) Neeltje E.M. van Haren et al. BIOLOGICAL PSYCHIATRY
- Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
- (2007) Stéphane Potvin et al. BIOLOGICAL PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started